Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;7(2):72-8.
doi: 10.1002/j.2051-5545.2008.tb00159.x.

Mild cognitive impairment: searching for the prodrome of Alzheimer's disease

Affiliations

Mild cognitive impairment: searching for the prodrome of Alzheimer's disease

Paul B Rosenberg et al. World Psychiatry. 2008.

Abstract

The concept of mild cognitive impairment (MCI) identifies persons who are neither cognitively normal nor demented. There is increasing evidence that MCI defines a group of persons who are at near-term risk of developing dementia and particularly Alzheimer's disease (AD). MCI thus constitutes an attractive target population for preventive treatments of AD. MCI is associated with aging and is more prevalent than dementia. There are several clinical and biological markers that are predictive of MCI prognosis, including depressive symptoms, cognitive deficits, brain imaging and neurochemical findings. The clinician needs to be especially alert to depressive and other mood symptoms which are common in MCI and potentially treatable. Trials of current medications for prevention of MCI progression to dementia have been largely negative. There are observational data suggesting that lifestyle modifications including exercise, leisure activities, cognitive stimulation, and social activities may be effective for prevention of MCI progression. There are many novel therapies currently in trials for early AD, and if effective they may prove to be helpful in prevention of MCI progression as well.

Keywords: Alzheimer's disease; Mild cognitive impairment; aging; depressive symptoms; exercise; prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mild cognitive impairment (MCI) and related syndromes (adapted from Rosenberg et al, 65)

References

    1. Ferri CP, Prince M, Brayne C. Alzheimer's Disease International: global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117. - PMC - PubMed
    1. Binetti G, Magni E, Padovani A. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;60:91–93. - PMC - PubMed
    1. Petersen RC, Doody R, Kurz A. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992. - PubMed
    1. Steinberg M, Shao H, Zandi P. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry. 2008;23:170–177. - PMC - PubMed
    1. Selkoe DJ. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest. 2002;110:1375–1381. - PMC - PubMed